A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Clinical trial NCT02663908 · TERMINATED
Trial details
- NCT number
- NCT02663908
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-19
- Primary completion
- 2021-03-29
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.